Neoplasms Clinical Trials

A listing of Neoplasms medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 8039 clinical trials
Targeting CD276 (B7-H3) Positive Solid Tumors by 4SCAR-276

The 4SCAR-CD276-modified T cells (4SCAR-276) can recognize and kill tumor cells through the recognition of CD276, a surface protein expressed at high levels on many types of tumors but at low levels on normal tissues.

neutrophil count
tyrosine
metastasis
immunohistochemistry
antibody therapy
  • 0 views
  • 19 Feb, 2024
  • 3 locations
4SCAR-T Therapy Post CD19-targeted Immunotherapy

This study will evaluate safety and efficacy of a combination of 4th generation chimeric antigen receptor gene-modified T cells (4SCAR-T) targeting CD19-negative B-ALL that express alternative surface antigens such as CD22, CD10, CD20, CD38, and CD123, as many patients relapse after anti-CD19 immunotherapy. Clinical response and optiminzation of a standardized …

  • 0 views
  • 19 Feb, 2024
  • 3 locations
Meaning-Centered Intervention for Muslim Patients Who Are Being Treated for Advanced Cancer

This study will compare the effectiveness of the Masterful supportive care intervention with that of the non-faith-based active control supportive care intervention, which uses the American Cancer Society's patient education materials, for Muslim patients who have advanced cancers.

cancer
advanced cancer
  • 0 views
  • 19 Feb, 2024
  • 1 location
RLY-1971 in Subjects With Advanced or Metastatic Solid Tumors

This study is a multi-center, open-label, dose escalation study of RLY-1971 in subjects with advanced or metastatic solid tumors.

hair thinning
metastatic malignant solid tumor
neuropathy
solid tumor
solid tumour
  • 0 views
  • 19 Feb, 2024
  • 4 locations
Tissue Retractors for Radiation Therapy of Head and Neck Tumors

The rate of therapy-associated side effects during and after radiotherapy of head and neck tumors is essential. The most effective approach to reducing acute toxicity is to cut out healthy tissue from the radiation field. The distance between the tumor and normal tissue can be individually increased using personalized, 3D …

dental caries
head and neck neoplasms
neck tumor
head and neck cancer
tumour resection
  • 0 views
  • 19 Feb, 2024
  • 1 location
Neoadjuvant Chemotherapy With or Without Metformin in Early Breast Cancer.

Several studies have pointed out a potentially beneficial effect of metformin therapy in diabetic cancer patients. Several studies are investigating the anti-tumor effect of metformin in early breast cancer. However, the enhancing effect of metformin on anti-tumor immunity has only been demonstrated in animal models.

cancer
preoperative chemotherapy
breast carcinoma
metastasis
breast cancer
  • 0 views
  • 19 Feb, 2024
  • 1 location
HER2-PREDICT: Translational Study of Tumor Samples From DS8201-A-U301 and DS8201-A-U302 Trials.

In order to identify mRNA ERBB2 levels, we will evaluate by gene expression tumor samples from these patients.

cancer
core needle biopsy
metastasis
breast cancer
HER2
  • 0 views
  • 19 Feb, 2024
  • 1 location
Dose-escalation Study of APG-1387 and Toripalimab in Solid Tumors

An ascending dose study in patients with solid tumors to evaluate the safety, tolerability, pharmacodynamics and efficacy of APG-1387 in combination with toripalimab. A phase II study of 3 cohorts will be included.

cancer
colorectal cancer
liver metastasis
small cell lung cancer
brain metastasis
  • 0 views
  • 19 Feb, 2024
  • 1 location
Study of AMG 650 in Adult Participants With Advanced Solid Tumors

To evaluate the safety and tolerability of AMG 650 in adult participants and to determine the maximum tolerated dose (MTD) and/or recommended phase 2 dose (RP2D).

  • 0 views
  • 19 Feb, 2024
  • 3 locations
A Study of SBT6050 in Patients With Advanced HER2 Expressing Solid Tumors

A first-in-human (FIH) study using SBT6050 in HER2 expressing advanced malignancies

cancer
pembrolizumab
measurable disease
solid tumor
solid tumour
  • 0 views
  • 19 Feb, 2024
  • 3 locations